Ubiquitin-Conjugating Enzyme E2G 1 (Ube2g1) (N-Term) Peptide
Ube2g1
Reactivity: Mouse
Host: Synthetic
BP, WB
Catalog No. ABIN985820
$160.46
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 11 to 17 Business Days
Quick Overview for Ubiquitin-Conjugating Enzyme E2G 1 (Ube2g1) (N-Term) Peptide (ABIN985820)
Target
UBE2G1 (Ube2g1)
(Ubiquitin-Conjugating Enzyme E2G 1 (Ube2g1))
Origin
Mouse
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequence
- GPPDTLYEGG VFKAHLTFPK DYPLRPPKMK FITEIWHPNV DKNGDVCISI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Ube2g1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- UBE2G1 (Ube2g1) (Ubiquitin-Conjugating Enzyme E2G 1 (Ube2g1))
-
Background
-
Ube2g1 accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro Ube2g1 catalyzes 'Lys-48'-, as well as 'Lys-63'-linked polyubiquitination. Ube2g1 may be involved in degradation of muscle-specific proteins and mediates polyubiquitination of CYP3A4.
Alias Symbols: 2700059C12Rik, AI256795, AU014992, AW552068, D130023C12Rik
Protein Size: 170 -
Molecular Weight
- 19 kDa
-
Gene ID
- 67128
-
NCBI Accession
- NM_025985, NP_080261
-
UniProt
- P62254
Target
-
You are here:
